Tag Archives: Zoloft

Florida drugging of Foster Care Children & resultant death of 7-year-old finally prompts state action

Gabriel Myer’s death on April 15 roiled child advocates, critics of the pharmaceutical industry, the media. But this week, a child’s suicide finally elicited a reaction where it matters. “I tell you, we’re going to do something. We’re going to do a full-court press,” said Florida State Sen. Tony Hill, a Jacksonville Democrat, still shocked after members of the Senate Children, Families and Elder Affairs Committee were briefed Wednesday by the Gabriel Myers Task Force.

New Study: Antidepressants Linked to Birth Defects

A Danish study shows that the risk is greatest when moms-to-be take more than one selective serotonin reuptake inhibitor (SSRI) antidepressant or switch SSRIs early in pregnancy. Babies born to women who had filled prescriptions for more than one SSRI had a fourfold increase in septal heart defects — a malformation of the wall that divides the left and right sides of the heart.

Behind the Marketing of antidepressants: Psychiatrists get more Pharma $$ than any other medical specialty

It is impossible to unpack all of the reasons for these prescriptions, but some industry critics say one reason could be the money doctors make from Forest. Psychiatrists make more money from drug makers than any other medical specialty, according to analyses of payment data. And Forest gives more money and food to doctors than many of its far larger rivals.

Exposing Psychiatry’s Billing Bible “Inside the DSM The Drug Barons’ Campaign to Make Us All Crazy”

Implicit to the drug companies’ messianic promises of health, happiness and economic productivity is a spurious parable of linear scientific progress: in spite of consistently inconclusive clinical trials, new psychotropic drugs are regularly marketed as improvements on old ones, ever more specific in their targeting of neurotransmitters, ever less productive of pernicious side effects.

FDA misleads again: Admits SSRI/suicide link for 25 & under but not adults

The FDA analysis by Dr. Marc Stone, Dr. Thomas Laughren and colleagues involved a review of data from eight drug makers on 372 clinical trials involving nearly 100,000 adults.

Overall, they found the risk of suicide was “strongly age-dependent,” with higher risks in people under 25, no difference among those 25 to 64, and lower risks in people 65 and older.